XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Selected financial info by reportable segment Selected financial information by reportable segment is presented below (in thousands):
 
Three Months Ended
March 31,
 
2019
 
2018
Revenues, net:
 
 
 
Prescription Pharmaceuticals
$
148,015

 
$
164,302

Consumer Health
17,856

 
19,761

Total revenues, net
165,871

 
184,063

 
 
 
 
Gross Profit:
 

 
 

Prescription Pharmaceuticals
45,443

 
73,508

Consumer Health
8,070

 
8,720

Total gross profit
53,513

 
82,228

 
 
 
 
Operating expenses
118,996

 
107,643

 
 
 
 
Operating (loss)
(65,483
)
 
(25,415
)
 
 
 
 
Other expenses, net
(15,278
)
 
(10,612
)
 
 
 
 
(Loss) before income taxes
$
(80,761
)
 
$
(36,027
)
Revenue from External Customers by Geographic Areas The following table sets forth the Company’s net revenues by geographic region for the three month periods ended March 31, 2019 and 2018. The Domestic region represents sales within the United States of America and its territories while the Foreign region represents sales within all other countries and territories (dollar amounts in thousands):
 
 
Three Months Ended
March 31, 2019
 
Three Months Ended
March 31, 2018
Region
Amount
 
% of Total Revenues
 
Amount
 
% of Total Revenues
Domestic
$
164,134

 
99.0%
 
$
181,015

 
98.3%
Foreign
1,737

 
1.0%
 
3,048

 
1.7%
Total Revenues
$
165,871

 
100.0%
 
$
184,063

 
100.0%